In the article “68Ga/177Lu-NeoBOMB1, A Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology” by Dalm et al. (J Nucl Med. 2017;58:293–299), the pmol values listed for Figure callouts 3A and 3B were switched in the paragraph providing the biodistribution of 177Lu-NeoBOMB1. The correct sentence should read “Figure 3 shows the results of the 177Lu-NeoBOMB1 biodistribution studies with 10 pmol (Fig. 3A) and with 200 pmol (Fig. 3B).” In addition, the Figure 3 legend should read “(A and B) Biodistribution of 10 and 200 pmol 177Lu-NeoBOMB1 in PC-3-xenografted animals, respectively.” The authors regret the errors.
- © 2018 by the Society of Nuclear Medicine and Molecular Imaging.
